| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/01/2001 | WO2001007455A1 Novel bicyclonucleoside analogues |
| 02/01/2001 | WO2001007433A2 Quinoline derivatives and their use as antibacterial agents |
| 02/01/2001 | WO2001007432A2 Aminopiperidine derivatives as antibacterials |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007412A1 Antiviral tetrahydroisichinolinsulfonamides |
| 02/01/2001 | WO2001007407A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 02/01/2001 | WO2001007403A1 Naphthyl-substituted sulfonamides |
| 02/01/2001 | WO2001007402A1 Antiviral agents |
| 02/01/2001 | WO2001007087A2 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | WO2001007079A1 Improvements in dispensing vaccines |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007057A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007042A1 Apicidin-derived cyclic tetrapeptides |
| 02/01/2001 | WO2001007035A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 02/01/2001 | WO2001007030A2 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2000061736A3 Recombinant and mutant marek's disease virus |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000061116A3 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 02/01/2001 | WO2000056362A3 Polycationic carbohydrates as immunostimulants in vaccines |
| 02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
| 02/01/2001 | WO2000056357A3 Staphylococcus antigen and vaccine |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000003743A3 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2718926A1 Methods of reducing microbial resistance to drugs |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380178A1 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 02/01/2001 | CA2380176A1 Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
| 02/01/2001 | CA2380171A1 Transposon mediated differential hybridisation |
| 02/01/2001 | CA2379834A1 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378849A1 Apicidin-derived cyclic tetrapeptides |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378395A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | CA2376961A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 02/01/2001 | CA2375650A1 Ehrlichia canis genes and vaccines |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072607A2 Purine L-nucleosides, analogs and uses therof |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071767A1 Gene coding for heliomicine and use thereof |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 01/31/2001 | EP1071758A1 Porcine adenovirus type 3 genome |
| 01/31/2001 | EP1071745A2 Process for synthesizing cox-2 inhibitors |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071699A1 Enhanced antisense modulation of icam-1 |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071693A1 Novel crystalline forms of an antiviral benzimidazole compound |
| 01/31/2001 | EP1071677A1 Production of furanones |
| 01/31/2001 | EP1071664A1 Substituted 2-oxo-alkanoic acid- 2-(indol-3-yl)-ethyl] amides |
| 01/31/2001 | EP1071475A2 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
| 01/31/2001 | EP1071474A1 Substituted porphyrins |
| 01/31/2001 | EP1071468A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 01/31/2001 | EP1071458A1 Humanized antibody and uses thereof |
| 01/31/2001 | EP1071457A1 Polymer particle vaccine delivery system |
| 01/31/2001 | EP1071456A1 Vaccines with an ltb adjuvant |
| 01/31/2001 | EP1071453A2 Live vaccines and methods of treatment therewith |
| 01/31/2001 | EP1071452A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof |
| 01/31/2001 | EP1071451A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/31/2001 | EP1071438A2 Stabilised virus preparation |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071413A1 Topical formulations for the treatment of nail fungal diseases |
| 01/31/2001 | EP1071412A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them |
| 01/31/2001 | EP1071409A2 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections |
| 01/31/2001 | EP1071407A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 01/31/2001 | EP1071377A1 Needleless administration of polynucleotide formulations |
| 01/31/2001 | EP1071334A1 A method for efficient and highly selective control of microorganisms |
| 01/31/2001 | EP0746320B1 Hiv protease inhibitors and intermediates |
| 01/31/2001 | EP0610356B1 Treatment of bacterial dysentery |
| 01/31/2001 | EP0598818B1 Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 01/31/2001 | CN1282335A Phosphonocephem derivatives, process for preparation of the same, and use thereof |
| 01/31/2001 | CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 01/31/2001 | CN1282255A IFNAR2/I FN complex |
| 01/31/2001 | CN1282251A Method and material for treating and preventing mucosal tissue inflammation |
| 01/31/2001 | CN1281863A Recombinant Newcastle disease virus capable of being used as embryo vaccine |
| 01/31/2001 | CN1281862A Three-chain formed oligonucleotide capable of inhibiting platelet derived growth factor gene expression and its application |
| 01/31/2001 | CN1281727A Antiviral composite containing phycocyanin extract and extraction of phycocyanin |
| 01/31/2001 | CN1281722A Chinese medicine preparation for discharging toxic material and curing cold and its production method |
| 01/31/2001 | CN1281712A New medicine for preventing and curing rabies |
| 01/31/2001 | CN1061351C Intermediates diaza or oxadiazabicyclic compounds |
| 01/31/2001 | CN1061348C New crystal modification of quinolinecarboxylic acid hydrochloride, process for its preparation and pharmaceutical formulations |
| 01/31/2001 | CN1061347C 抗真菌剂 Antifungal agents |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/31/2001 | CN1061258C Chinese medicine powder for curing ringworm of foot, and preparing method |
| 01/31/2001 | CN1061247C Medicine for curing tuberculosis |
| 01/31/2001 | CN1061213C Method for combating fish parasites |
| 01/30/2001 | US6180816 Anti-viral compounds |
| 01/30/2001 | US6180815 Compounds which abrogate hemagglutinin-mediated fusion of virus-host membranes; treating influenza |
| 01/30/2001 | US6180782 Preparation of clavulanate salts |
| 01/30/2001 | US6180766 Nucleosides and oligonucleotides containing boron clusters |
| 01/30/2001 | US6180681 2-cyclopenten-1-one as an inducer of HSP70 |